Hyperion Defi (HYPD) Cash from Financing Activities (2017 - 2026)
Hyperion Defi (HYPD) posted quarterly Cash from Financing Activities of $6.6 million for Q1 2026, up 5.6% year-over-year from $6.3 million in Q1 2025, and down 23.15% quarter-over-quarter from $8.6 million in Q4 2025.
Hyperion Defi (HYPD) Cash from Financing Activities (2017 - 2026) Analysis & Trends
Hyperion Defi (HYPD) has reported Cash from Financing Activities for 10 consecutive years, with $6.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Financing Activities rose 5.6% year-over-year to $6.6 million; the TTM figure through Mar 2026 stood at $91.4 million (up 341.99% YoY), while the FY2025 annual figure was $91.0 million, up 418.64% from the prior year.
- Cash from Financing Activities retreated to $6.6 million in Q1 2026 per HYPD's latest filing, from $8.6 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $52.6 million in Q2 2025 and bottomed at -$318505.0 in Q2 2022.
- Historically, Cash from Financing Activities has averaged $9.2 million across 5 years, with a median of $5.0 million in 2023.
- Annual changes were most pronounced in 2022 — Cash from Financing Activities plunged 104.03% — and 2025, when it soared 1965.53%.
- Hyperion Defi's Cash from Financing Activities stood at $3.3 million in 2022, then tumbled by 81.42% to $614273.0 in 2023, then surged by 70.0% to $1.0 million in 2024, then jumped by 723.27% to $8.6 million in 2025, then dropped by 23.15% to $6.6 million in 2026.
- Business Quant data shows HYPD's Cash from Financing Activities at $6.6 million in Q1 2026, $8.6 million in Q4 2025, and $23.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -426.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -1.22 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 14.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -6.05 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 36.24 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -16.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 27.18 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -273.15 Mn |
| 10 | Hyperion Defi | 44.93 Mn | 35.29 Mn | 357,693.00 | 10.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.77 Mn |
| Jun 30, 2026 | 10.77 Mn |
| Mar 31, 2026 | 6.61 Mn |
| Mar 31, 2026 | 6.61 Mn |
| Dec 31, 2025 | 8.60 Mn |
| Dec 31, 2025 | 8.60 Mn |
| Sep 30, 2025 | 23.63 Mn |
| Sep 30, 2025 | 23.63 Mn |
| Jun 30, 2025 | 52.57 Mn |
| Jun 30, 2025 | 52.57 Mn |
| Mar 31, 2025 | 6.26 Mn |
| Mar 31, 2025 | 6.26 Mn |
| Dec 31, 2024 | 1.04 Mn |
| Dec 31, 2024 | 1.04 Mn |
| Sep 30, 2024 | 10.83 Mn |
| Sep 30, 2024 | 10.83 Mn |
| Jun 30, 2024 | 2.54 Mn |
| Jun 30, 2024 | 2.54 Mn |
| Mar 31, 2024 | 3.13 Mn |
| Mar 31, 2024 | 3.13 Mn |